Promising innovative combination therapy for Burkitt’s lymphoma
Burkitt’s lymphoma is a rare and aggressive blood cancer characterised by a translocation of the…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
A nuclear target to revive anti-tumour immunity
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified…
Inflammatory immune cells predict survival, relapse in multiple myeloma
A new study maps the immune cell landscape of bone marrow in patients with multiple…
Potential anti-cancer fungal compound finally synthesised after 55 years
The fungal compound verticillin A, discovered more than 50 years ago, has long been regarded…
Cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking oestrogen,…
Researchers develop treatment for advanced prostate cancer that could eliminate severe side effects
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could…
Mapping cancer’s weak spots reveals new precision targets for breast cancer
Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies.…
ASCO GI 2026: Zanidatamab and chemotherapy can slow cancer growth, extend survival in some people with gastroesophageal adenocarcinoma
Results from a new phase 3 study found that for people with human epidermal growth…
Method developed to identify best treatment combinations for glioblastoma based on unique cellular targets
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets…
Scientists uncover a hidden switch that helps cancer cells thrive
Scientists have uncovered evidence that two defining features of cancer are driven by the same…